latest news releases from the newsroom
Equistar to Sell Bayport Polypropylene Unit and Agrees to Long Term Propylene Supply Agreement for a Total of $190 Million
RED BANK, N.J., March 27, 2003 (PRIMEZONE) -- Millennium Chemicals (NYSE:MCH) ("Millennium") today announced that its joint venture Equistar Chemicals, L.P. is entering into a long-term propylene supply arrangement with Sunoco, Inc. and is selling its Bayport polypropylene manufacturing unit in Pasadena, Texas, to Sunoco, subject to certain conditions. The total consideration to Equistar for the supply arrangements and asset sale is approximately $190 million, plus the value of the Bayport polypropylene inventory. The transaction will be effective as of March 31.
UTi Worldwide to Report Fiscal 2003 Fourth Quarter and Year Results on April 2
RANCHO DOMINGUEZ, Calif., March 27, 2003 (PRIMEZONE) -- UTi Worldwide Inc. (Nasdaq:UTIW) today announced that, prior to market open on Wednesday, April 2, the company will report financial results for its fiscal fourth quarter and year ended January 31, 2003. The company also said that it will host an investor conference call the same day at 8:00 a.m. PST (11:00 a.m. EST) to review UTi's financials and operations for the quarter.
Capio takes over The Eye Academy (London) Ltd.
GOTHENBURG, Sweden, March 27, 2003 (PRIMEZONE) -- Capio Healthcare UK has acquired of The Eye Academy (London) Ltd. in Harley Street. Capio (Other OTC:CPOOF) will be developing the Harley Street site into the first of its U.K. based "Capio Eye" centers based on the Swedish designed Medocular Eye clinics.
BioXell Initiates Phase II Clinical Trial with BXL-628 in Benign Prostatic Hyperplasia
MILAN, Italy, March 27, 2003 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company, today announced that it has initiated recruitment for the Phase II trial of its novel lead compound, BXL-628, in Benign Prostatic Hyperplasia (BPH).The trial, a double-blind, randomised, placebo-controlled study involving 120 patients, will be coordinated by the Division of Urology, Universita Vita e Salute-San Raffaele, Milan and involve 12 centres across Italy.
Allgon Appointed as PDH Microwave Supplier to Marconi
TABY, Sweden, March 27, 2003 (PRIMEZONE) -- Allgon (Other OTC:ALGBF), a global supplier of radio-based infrastructure solutions, has signed a worldwide supply agreement with Marconi Communications GmbH for the supply of Plesiochronous Digital Hierarchy (PDH) Microwave equipment to complement Marconi's range of Fixed Wireless communications solutions.